Reframing personalised treatment decisions in advanced ovarian cancer in 2023
May 25th, 2023 18:30-20:30
Once approved, we will contact you with your joining link for this event.
Dr. Dearbhaile Collins
Cork University Hospital, Ireland
What's changed in the PARPi treatment landscape in 2022?
Professor Charlie Gourley
Edinburgh University Hospital, United Kingdom
The art of personalising first-line maintenance treatment selection
Professor Jonathan Ledermann
University College London Cancer Institute
What is the clinical relevance of recent overall survival data readouts in recurrent ovarian cancer?
20:05 - 20:30
Panel & Audience Discussion
NX-IE-NRP-WCNT-230002 April 2023